This study evaluated the impact of 9 single nucleotide polymorphisms (SNPs) in 6 candidate genes (APOB, APOA5, APOE, APOC3, SCAP, and LDLR) over dyslipidemia in HIV-infected patients on stable antiretroviral therapy (ART) with undetectable viral loads. Blood samples were collected from 614 patients at reference services in the cities of Porto Alegre, Pelotas, and Rio Grande in Brazil. The SNPs were genotyped by conventional polymerase chain reaction (PCR) and real-time PCR. The prevalence of dyslipidemia was particularly high among the protease inhibitors-treated patients (79%). APOE (rs429358 and rs7412) genotypes and APOA5 -1131T>C (rs662799) were associated with plasma triglycerides (TG) and low-density-lipoprotein cholesterol levels (LDL-C). The APOA5 -1131T>C (rs662799) and SCAP 2386A>G (rs12487736) polymorphisms were significantly associated with high-density-lipoprotein cholesterol levels. The mean values of the total cholesterol and LDL-C levels were associated with both the APOB SP Ins/Del (rs17240441) and APOB XbaI (rs693) polymorphisms. In conclusion, our data support the importance of genetic factors in the determination of lipid levels in HIV-infected individuals. Due to the relatively high number of carriers of these risk variants, studies to verify treatment implications of genotyping before HAART initiation may be advisable to guide the selection of an appropriate antiretroviral therapy regimen.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804371 | PMC |
| http://dx.doi.org/10.1155/2013/608415 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Prevalence of dyslipidemia and influencing factors in HIV-infected people before starting antiretroviral therapy in China, 2018-2023].
Zhonghua Liu Xing Bing Xue Za Zhi
January 2025
Division of Treatment and Care,National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing102206, China.
To investigate the prevalence of baseline dyslipidemia in HIV-infected people before starting antiviral therapy (ART) in China. The data were collected from HIV/AIDS ART database of Chinese Disease Prevention and Control Information System. A national sample of HIV- infected people who initiated ART from 2018 to 2023 was used to collect baseline information, including sociodemographic characteristics and laboratory test results.
View Article and Find Full Text PDFPrevalence of metabolic dysfunction-associated steatotic liver disease in people living with HIV and on antiretroviral treatment: A systematic review and meta-analysis protocol.
Health Sci Rep
November 2024
Department of Physiology, Faculty of Health Sciences University of Pretoria Gauteng South Africa.
Article Synopsis
- Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver condition worldwide, often linked to factors like obesity and type 2 diabetes, with increased risk observed in HIV-infected individuals due to their antiretroviral therapy.
- The research protocol outlines methods for a systematic review and meta-analysis focused on the global prevalence of MASLD in HIV patients on antiretroviral treatment, employing comprehensive literature searches from various databases.
- Eligible studies will include observational and clinical trials published in English since 1990, while excluding animal research, and the selected studies will be evaluated for bias and evidence quality using established tools.
Obesity Defining Criteria, and Association with Cardiovascular Disease Risk Factors Among People Living with HIV in Jos, Nigeria.
Niger Med J
September 2024
Department of Chemical Pathology and Metabolic Medicine, Jos University Teaching Hospital, Plateau State, Nigeria.
Article Synopsis
- - The study investigates the connection between obesity criteria and cardiovascular disease indicators in people living with HIV (PLHIV), focusing on 140 HIV-infected patients in Nigeria.
- - It finds a varying prevalence of obesity based on different criteria, with only 9.3% showing obesity across all four measures; BMI correlated with hypertension, while waist-hip-ratio linked to both hypertension and dyslipidaemia.
- - The research suggests that a standardized assessment of obesity, particularly central obesity, is crucial for evaluating cardiovascular risk in PLHIV, as no significant relationship was found between obesity and HIV-related factors.
Correlation of APOE polymorphism, expression, and plasma levels with cardiac comorbidities among lipodystrophy in HIV-infected patients.
Clin Chim Acta
January 2025
Department of Molecular Biology, National AIDS Research Institute Pune 411026, India. Electronic address:
Article Synopsis
- - The study examined the impact of ApoE gene polymorphisms on HIV-related lipodystrophy (HIVLD) and metabolic abnormalities in 200 HIV-infected patients, revealing that certain genotypes might influence the risk of developing these conditions.
- - Results indicated that ApoE alleles 2 and specific genotypes, like 4/4, were connected to a decreased risk of HIV-1 infection and a lower likelihood of severe HIVLD, whereas allele 2 was linked to increased risk of both HIV acquisition and HIVLD severity.
- - Additionally, the study found correlations between specific ApoE genotypes and impaired cholesterol and glucose levels in patients without HIVLD, highlighting the intricate relationship between genetics and metabolic health in the context
The risk of dyslipidemia on PLHIV associated with different antiretroviral regimens in Huzhou.
PLoS One
September 2024
Division of Epidemiology and Health Statistics, Department of Preventive Medicine, School of Public Health & Management, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Background: Dyslipidemia is increasingly common in people living with HIV (PLHIV), thereby increasing the risk of cardiovascular events and diminishing the quality of life for these individuals. The study of blood lipid metabolism of PLHIV has great clinical significance in predicting the risk of cardiovascular disease. Therefore, this study aims to examine the blood lipid metabolism status of HIV-infected patients in Huzhou before and after receiving highly active antiretroviral therapy (HAART) and to explore the impact of different HAART regimens on dyslipidemia.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!